tiprankstipranks
Exscientia Plc Backs Acquisition by Recursion Pharmaceuticals
Company Announcements

Exscientia Plc Backs Acquisition by Recursion Pharmaceuticals

Exscientia Plc (EXAI) has released an update.

Pick the best stocks and maximize your portfolio:

Exscientia Plc has committed to an irrevocable undertaking favoring the acquisition of its issued and to-be-issued share capital by Recursion Pharmaceuticals, Inc. The agreement includes strict terms ensuring Exscientia’s shareholders will not entertain other offers and will vote in support of the acquisition. The deal is set to proceed either through a court-sanctioned scheme of arrangement or a takeover offer, as detailed in the transaction agreement.

For further insights into EXAI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyTwo new option listings and one option delisting on November 21st
TipRanks Auto-Generated NewsdeskExscientia and Recursion Merge to Revolutionize Drug Discovery
TheFlyRecursion, Exscientia officially combine to advance drug discovery
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App